These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18383118)

  • 1. Regression of symptoms after selective iron chelation therapy in a case of neurodegeneration with brain iron accumulation.
    Forni GL; Balocco M; Cremonesi L; Abbruzzese G; Parodi RC; Marchese R
    Mov Disord; 2008 Apr; 23(6):904-7. PubMed ID: 18383118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological variability in neurodegeneration with brain iron accumulation.
    Vincze A; Kapás I; Molnar MJ; Kovács GG
    Ideggyogy Sz; 2010 Mar; 63(3-4):129-35. PubMed ID: 20405671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodegeneration with brain iron accumulation--late onset slowly progressive variant.
    Patil PV; Manakshe G; Mahajan DP; Solanke DB; Sakale T
    J Assoc Physicians India; 2011 May; 59():319-21. PubMed ID: 21751611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Childhood disorders of neurodegeneration with brain iron accumulation (NBIA).
    Kurian MA; McNeill A; Lin JP; Maher ER
    Dev Med Child Neurol; 2011 May; 53(5):394-404. PubMed ID: 21480873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic advances in neurodegeneration with brain iron accumulation.
    Zorzi G; Zibordi F; Chiapparini L; Nardocci N
    Semin Pediatr Neurol; 2012 Jun; 19(2):82-6. PubMed ID: 22704261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of deferiprone for the treatment of pantothenate kinase-associated neurodegeneration (PKAN) and neurodegeneration with brain iron accumulation (NBIA): results from a four years follow-up.
    Cossu G; Abbruzzese G; Matta G; Murgia D; Melis M; Ricchi V; Galanello R; Barella S; Origa R; Balocco M; Pelosin E; Marchese R; Ruffinengo U; Forni GL
    Parkinsonism Relat Disord; 2014 Jun; 20(6):651-4. PubMed ID: 24661465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodegeneration with brain iron accumulation: clinical, radiographic and genetic heterogeneity and corresponding therapeutic options.
    Clement F; Devos D; Moreau C; Coubes P; Destee A; Defebvre L
    Acta Neurol Belg; 2007 Mar; 107(1):26-31. PubMed ID: 17569231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodegeneration with brain iron accumulation.
    Dusek P; Schneider SA
    Curr Opin Neurol; 2012 Aug; 25(4):499-506. PubMed ID: 22691760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autopsy always teach and tell: neurodegeneration with brain iron accumulation: a case report.
    Gupta R; Kumar A; Sharma MC; Sarkar C; Goyal V; Bihari M
    Indian J Pathol Microbiol; 2007 Oct; 50(4):792-4. PubMed ID: 18306557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of T2* magnetic resonance in monitoring iron chelation therapy.
    Carpenter JP; Pennell DJ
    Acta Haematol; 2009; 122(2-3):146-54. PubMed ID: 19907152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aceruloplasminemia: a novel mutation in a family with marked phenotypic variability.
    Fasano A; Colosimo C; Miyajima H; Tonali PA; Re TJ; Bentivoglio AR
    Mov Disord; 2008 Apr; 23(5):751-5. PubMed ID: 18200628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redox active iron accumulation in aceruloplasminemia.
    Gonzalez-Cuyar LF; Perry G; Miyajima H; Atwood CS; Riveros-Angel M; Lyons PF; Siedlak SL; Smith MA; Castellani RJ
    Neuropathology; 2008 Oct; 28(5):466-71. PubMed ID: 18282164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron and multiple sclerosis.
    Stankiewicz JM; Neema M; Ceccarelli A
    Neurobiol Aging; 2014 Sep; 35 Suppl 2():S51-8. PubMed ID: 24929968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotection: a new strategy in the treatment of schizophrenia. Neurobiological basis of neurodegeneration and neuroprotection.
    Lieberman JA
    CNS Spectr; 2007 Oct; 12(10 Suppl 18):4-6. PubMed ID: 17934388
    [No Abstract]   [Full Text] [Related]  

  • 15. Iron and Parkinson's disease.
    Di Lorenzo F
    Neuro Endocrinol Lett; 2015; 36(1):24-7. PubMed ID: 25789591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of iron overload in thalassemia.
    Cianciulli P
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():208-13. PubMed ID: 19337180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superficial siderosis: a case report and review of the literature.
    Levy M; Turtzo C; Llinas RH
    Nat Clin Pract Neurol; 2007 Jan; 3(1):54-8; quiz 59. PubMed ID: 17205075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre.
    Gamberini MR; De Sanctis V; Gilli G
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():158-69. PubMed ID: 19337172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging of iron.
    Dusek P; Dezortova M; Wuerfel J
    Int Rev Neurobiol; 2013; 110():195-239. PubMed ID: 24209440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal changes in free iron levels after brain ischemia Relevance to the timing of iron chelation therapy in stroke.
    Millerot-Serrurot E; Bertrand N; Mossiat C; Faure P; Prigent-Tessier A; Garnier P; Bejot Y; Giroud M; Beley A; Marie C
    Neurochem Int; 2008 Jun; 52(8):1442-8. PubMed ID: 18485533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.